• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症、COVID-19 和预防原则：在全球大流行期间优先考虑治疗。

Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.

机构信息

Department of Oncology, Queen's University, Kingston, Ontario, Canada.

Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

出版信息

Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.

DOI:10.1038/s41571-020-0362-6
PMID:32242095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7117554/
Abstract

During the COVID-19 global pandemic, the cancer community faces many difficult questions. We will first discuss safety considerations for patients with cancer requiring treatment in SARS-CoV-2 endemic areas. We will then discuss a general framework for prioritizing cancer care, emphasizing the precautionary principle in decision making.

摘要

在 COVID-19 全球大流行期间，癌症领域面临着许多难题。我们首先将讨论在 SARS-CoV-2 流行地区需要治疗的癌症患者的安全注意事项。然后，我们将讨论癌症治疗的优先顺序的总体框架，强调决策中的预防原则。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336f/7117554/8173eac466ca/41571_2020_362_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336f/7117554/8173eac466ca/41571_2020_362_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336f/7117554/8173eac466ca/41571_2020_362_Fig1_HTML.jpg

相似文献

1
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.癌症、COVID-19 和预防原则：在全球大流行期间优先考虑治疗。
Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.
2
Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic.在新冠疫情期间进行微创手术时SARS-CoV-2传播的风险
Eur Urol. 2020 Jul;78(1):e12-e13. doi: 10.1016/j.eururo.2020.04.015. Epub 2020 Apr 13.
3
VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic.COVID-19大流行期间膀胱癌管理中替代风险适应性策略的VI-RADS评分标准
Eur Urol. 2020 Jul;78(1):e18-e20. doi: 10.1016/j.eururo.2020.04.043. Epub 2020 Apr 27.
4
Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic.2019冠状病毒病大流行期间食管癌放射治疗的考量
Clin Oncol (R Coll Radiol). 2020 Jun;32(6):354-357. doi: 10.1016/j.clon.2020.04.001. Epub 2020 Apr 9.
5
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1471. doi: 10.1001/jamaoncol.2020.2583.
6
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1470-1471. doi: 10.1001/jamaoncol.2020.2580.
7
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1471-1472. doi: 10.1001/jamaoncol.2020.2586.
8
Risk of COVID-19 in Patients With Cancer.癌症患者感染新型冠状病毒肺炎的风险
JAMA Oncol. 2020 Sep 1;6(9):1469-1470. doi: 10.1001/jamaoncol.2020.2577.
9
International Mental Health perspectives on the novel coronavirus SARS-CoV-2 pandemic.关于新型冠状病毒SARS-CoV-2大流行的国际心理健康视角。
Rev Psiquiatr Salud Ment (Engl Ed). 2020 Apr-Jun;13(2):111-113. doi: 10.1016/j.rpsm.2020.04.002. Epub 2020 Apr 17.
10
Risk of COVID-19 for patients with cancer.癌症患者感染新冠病毒的风险。
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.

引用本文的文献

1
Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process.关于研究癌症诊断至治疗间隔与总生存期之间关联的建议：一种改良的德尔菲法。
Br J Cancer. 2025 Sep 5. doi: 10.1038/s41416-025-03158-3.
2
COVID-19 Induces Prolonged Immunological Exhaustion Leading to Relapse of Hematological Malignancies Except in Hematopoietic Cell Transplant Recipients.除造血细胞移植受者外，新冠病毒疾病（COVID-19）会引发长期免疫耗竭，导致血液系统恶性肿瘤复发。
Mediterr J Hematol Infect Dis. 2025 May 1;17(1):e2025042. doi: 10.4084/MJHID.2025.042. eCollection 2025.
3

本文引用的文献

1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
3
COVID-19 Pandemic Conditions Affecting QoL and Mental Health of Oncology Patients in Poland.
影响波兰肿瘤患者生活质量和心理健康的新冠疫情状况
Cancers (Basel). 2025 Feb 16;17(4):662. doi: 10.3390/cancers17040662.
4
COVID-19-Related Treatment Cancellations and Oncology Patients' Psychological Health in Nigeria.尼日利亚因 COVID-19 相关治疗取消而导致的肿瘤患者心理健康问题
Clin Med Res. 2024 Jun;22(2):61-75. doi: 10.3121/cmr.2024.1854.
5
The impact of the COVID-19 pandemic on health-related quality of life of cancer patients in British Columbia.不列颠哥伦比亚省癌症患者的 COVID-19 大流行对其健康相关生活质量的影响。
J Patient Rep Outcomes. 2024 Aug 23;8(1):100. doi: 10.1186/s41687-024-00759-z.
6
What does "urgency" mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic.在优先考虑癌症治疗时，“紧迫性”意味着什么？在 COVID-19 大流行期间，德国肿瘤学家和其他专家进行的定性研究结果。
J Cancer Res Clin Oncol. 2024 Jul 15;150(7):352. doi: 10.1007/s00432-024-05863-7.
7
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic.妇科肿瘤学中的患者护理和临床试验获取：COVID-19 大流行早期的全球影响。
Arch Gynecol Obstet. 2024 Jul;310(1):577-586. doi: 10.1007/s00404-024-07511-4. Epub 2024 Jun 5.
8
Assessment of the dynamics of inpatient health care delivery in Poland before and throughout the COVID-19 pandemic.评估波兰在 COVID-19 大流行之前和整个期间住院医疗服务提供的动态。
Sci Rep. 2024 May 25;14(1):11975. doi: 10.1038/s41598-024-62671-2.
9
Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.COVID-19 大流行期间治疗儿科癌症患者的挑战：平衡风险和护理。
Viruses. 2024 Apr 26;16(5):690. doi: 10.3390/v16050690.
10
Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic: a nationwide population-level study.2020年新冠疫情期间乳腺癌的发病率、分期分布及治疗变化：一项全国性的人群水平研究
Arch Public Health. 2024 May 7;82(1):66. doi: 10.1186/s13690-024-01296-3.
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
4
The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits.基于证据的放疗的人群获益：5 年局部控制和总生存获益。
Radiother Oncol. 2018 Feb;126(2):191-197. doi: 10.1016/j.radonc.2017.11.004. Epub 2017 Dec 8.
5
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.辅助化疗开始时间与乳腺癌生存率之间的关系：一项系统评价和荟萃分析。
Breast Cancer Res Treat. 2016 Nov;160(1):17-28. doi: 10.1007/s10549-016-3960-3. Epub 2016 Sep 8.
6
Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.辅助化疗起始时间与结直肠癌生存的关系：系统评价和荟萃分析。
JAMA. 2011 Jun 8;305(22):2335-42. doi: 10.1001/jama.2011.749.
7
The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature.放射治疗等待时间与临床结局之间的关系：文献系统综述
Radiother Oncol. 2008 Apr;87(1):3-16. doi: 10.1016/j.radonc.2007.11.016. Epub 2007 Dec 21.